Schroder Investment Management Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-182,800
Closed -$31.6M 1321
2015
Q1
$31.6M Sell
182,800
-121,400
-40% -$17.8M 0.06% 366
2014
Q4
$35M Buy
304,200
+940
+0.3% +$114K 0.07% 333
2014
Q3
$47.4M Sell
303,260
-27,400
-8% -$3.97M 0.06% 286
2014
Q2
$40.8M Sell
330,660
-45,440
-12% -$5.02M 0.05% 323
2014
Q1
$39M Sell
376,100
-330,200
-47% -$33.8M 0.04% 313
2013
Q4
$63.5M Sell
706,300
-53,900
-7% -$4.3M 0.08% 205
2013
Q3
$50.8M Sell
760,200
-38,000
-5% -$2.62M 0.12% 207
2013
Q2
$52.8M Buy
+798,200
New +$45.6M 0.14% 182

Other funds holding SLXP

Schroder Investment Management Group's SLXP Position: Q2 2015 in Review

Schroder Investment Management Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 182,800 shares — an estimated $31.6M sold.

Schroder Investment Management Group first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $63.5M in Q4 2013. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Schroder Investment Management Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Schroder Investment Management Group sold 182,800 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $31.6M.
  • Schroder Investment Management Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Schroder Investment Management Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $63.5M in Q4 2013.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Schroder Investment Management Group's 13F filing for Q2 2015, filed 10 Aug 2015.